First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic

OBJECTIVE: Helicobacter pylori (HP) is the world’s most common infectious agent. Despite conventional therapy consisting of proton pump inhibitor (PPI), amoxicillin (AMO) and clarithromycin (CLA), approximately half of the patients remain infected. We compared the PPI-based triple therapy with quadr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ulus Cerrahi Derg
Autores principales: Özbalcı, Gökhan Selçuk, Yürüker, Saim Savaş, Tarım, İsmail Alper, Çınar, Hamza, Polat, Ayfer Kamalı, Özbalcı, Aysu Başak, Karabulut, Kağan, Erzurumlu, Kenan
Formato: Artigo
Lenguaje:Inglês
Publicado: Turkish Journal of Surgery 2014
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379858/
https://ncbi.nlm.nih.gov/pubmed/25931914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/UCD.2014.2678
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares